Carregant...
Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
BACKGROUND AND AIMS: Anti‐Tumor Necrosis Factor (TNF)‐induced lupus (ATIL) is a distinct clinical entity, increasingly recognized in patients with inflammatory bowel disease treated with anti‐TNF therapy. Our aims were to evaluate the incidence and clinical and serological markers of ATIL in this po...
Guardat en:
| Publicat a: | JGH Open |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley Publishing Asia Pty Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7273700/ https://ncbi.nlm.nih.gov/pubmed/32514462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12291 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|